-
Founded in:
2005-01-01 -
Country:
China -
Address:
No. 6, Chuangye East Road, High-tech Industrial Development Zone, Ankang City, Shaanxi Province -
Tax NO.:
916100002229143509 -
Registered Funds:
119.34 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gynostemma pentaphyllumsaponins |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Matrine |
Inhibits the replication of hepatitis B HbeAg, improves the symptoms and signs of pathological hepatitis, and has anti-cancer and anti-arrhythmic effects
More
Inhibits the replication of hepatitis B HbeAg, improves the symptoms and signs of pathological hepatitis, and has anti-cancer and anti-arrhythmic effects |
519-02-8 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clarithromycin |
This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect.
More
This product is a macrolide antibiotic, which has inhibitory effects on Gram-positive bacteria such as Staphylococcus aureus, Streptococcus, and Pneumococcus, as well as some Gram-negative bacteria such as Haemophilus influenzae, Bordetella pertussis, Neisseria gonorrhoeae, Legionella pneumophila, and some anaerobic bacteria such as Bacteroides fragilis, Streptococcus peptostreptococcus, and Propionibacterium acnes. In addition, it also has inhibitory effects on mycoplasma. The characteristics of this product are that its antibacterial activity in vitro is similar to that of erythromycin, but its antibacterial activity in vivo against some bacteria such as Staphylococcus aureus, Streptococcus, and Haemophilus influenzae is stronger than that of erythromycin. There is cross-resistance between this product and erythromycin. The mechanism of action of this product is to inhibit the association of the 50S subunit of the nuclear protein and inhibit protein synthesis to produce an antibacterial effect. |
81103-11-9 | 46 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Astragali Radix |
|
0 | ||
| Salvia Root P.E Tanshinone IIA 20% |
|
0 | ||
| Prunella vulgaris |
|
0 | ||
| D(+)-Trehalose dihydrate |
|
6138-23-4 | 9 | |
| Ostracean |
|
0 | ||
| Trichosanthes Fruit Extract |
|
0 | ||
| Scrophulariae Radix |
|
0 | ||
| Rhizoma Sparganii Extract |
|
0 | ||
| Zedoary turmeric |
|
0 | ||
| MYRRH GUM |
|
9000-45-7 | 0 | |
| OLIBANUM GUM |
|
8050-07-5 | 0 | |
| FRITILLARIAE THUNBERGII BULBUS |
|
0 |